Lytix Biopharma ASA (OSL:LYTIX)
Norway
· Delayed Price · Currency is NOK 10.20
-0.10 (-0.97%)
Apr 29, 2026, 4:29 PM CET
Lytix Biopharma ASA Revenue
Revenue
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
14
Market Cap
792.07M
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Zelluna ASA | 53.00K |
| ArcticZymes Technologies ASA | 118.21M |
| Nykode Therapeutics AS | 4.57M |
| Thor Medical ASA | 839.00K |
| Circio Holding ASA | 123.00K |
| SoftOx Solutions AS | 15.58M |
| Oncoinvent ASA | 28.07M |
| Arctic Bioscience AS | 45.90M |
Lytix Biopharma ASA News
- 2 months ago - Lytix Biopharma ASA Earnings Call Transcript: Q4 2025 - Transcripts
- 5 months ago - Lytix Biopharma ASA Earnings Call Transcript: Q3 2025 - Transcripts
- 8 months ago - Lytix Biopharma ASA Earnings Call Transcript: Q2 2025 - Transcripts
- 1 year ago - Lytix Biopharma ASA Earnings Call Transcript: Q1 2025 - Transcripts
- 1 year ago - Lytix Biopharma ASA Earnings Call Transcript: Q4 2024 - Transcripts
- 1 year ago - Lytix Biopharma ASA Earnings Call Transcript: Q3 2024 - Transcripts
- 1 year ago - Lytix Biopharma ASA Earnings Call Transcript: Q2 2024 - Transcripts
- 1 year ago - Lytix Biopharma ASA Transcript: Study Update - Transcripts